companies / aivocode-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-16 json
| total_raised | 2,600,0002.6M | ○ |
|---|---|---|
| founded | null | |
| hq | san diego, ca, usa | |
| industry | unknown | |
| stage | null |
AivoCode develops therapeutics for neurological disease using molecular zip-code-based platform technology. It targets patients with traumatic brain injury, neurodegenerative disease, and ophthalmic conditions. Differentiator: identifies disease-specific molecular markers to enable neuroprotection and block neuroinflammation.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-01-01 | grant | 2,600,0002.6M | null | ○ |
Typekit, Adobe Fonts, Afterpay, Sentry, Squarespace, Squarespace Commerce, Stimulus, parallax.js, web-vitals, moment 0, @sentry/browser
| fact | status | src |
|---|---|---|
| Grant, $2.6M | attributed | ○ |
| existence | sourced | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-10-17provenance_existence: self-reported → sourced, WEB 2026-10-17 | provenance_existence | self-reported → sourced | WEB 2026-10-17 |
Records begin 2026-09-24. all_changes